Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cytokine Injection Sites for Stem Cell Mobilization
NCT00646763Phase 2Terminated
- Sponsor
- Emory University
- Start
- Apr 2008
- Primary completion
- Sep 2009
- Modality
- Cytokines & Interferons
- Countries
- 1
01
Overview
A Phase 2 trial of filgrastim, sargramostim in Hodgkin lymphoma (HL), non-Hodgkin lymphoma (NHL), multiple myeloma (MM), sponsored by Emory University. Started Apr 2008; status: terminated.
02
Drugs
filgrastimsargramostim
03
Conditions
Hodgkin lymphoma (HL)non-Hodgkin lymphoma (NHL)multiple myeloma (MM)
Beyond the preview
Go deeper on NCT00646763.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00646763.